![]() She is among other principal investigators of the strategic public-private partnership Precision Medicine for More Oxygen (P4O2), and president of the Federation Innovative Medicine Research Netherlands (FIGON). She published more than 310 peer-reviewed articles. Moving away from using old-fashioned diagnostic labels, and instead using biomarkers to understand biological pathways and optimize therapy for the individual patient accordingly. Her main research goal is to bring precision medicine into clinical practice. In 2005, she started to work at Utrecht University, first as an assistant professor and, in 2012, as an associate professor in Precision Medicine. From 2003 to 2005, she worked as a post-doc at the Human Genetics Center of the University of Texas in Houston. In 2016, she was appointed full professor in the Amsterdam UMC (Precision Medicine in Respiratory Disease). What is it like to work in such a consortium and is this the future of research funding? About the SpeakerĪnke-Hilse Maitland-Van der Zee was trained as a pharmacist, clinical pharmacologist and epidemiologist. Furthermore, the collaboration in a large public-private partnership, Precision Medicine for More Oxygen ( P4O2), will be discussed. Different omics layers (microbiome, transcriptome, metabolome) are used to identify phenotypes and possible first steps towards personalization of medicine for this patient group will be discussed. In this talk, results from many studies in both adult and pediatric asthma populations will be shown. This can lead to the development of the optimal treatment for the individual patient. Precision medicine can help identify the biological background of the disease in this group of patients and recognize so-called phenotypes. Many patients with asthma are well-controlled on existing medication however, a group of severe asthma patients still have many complaints even if treated according to guidelines. Location: Tom and Linda Atkins Family Seminar Room, Roy Blunt NextGen Precision Health building Description Speaker: Anke-Hilse Maitland-van der Zee, PhD, Professor, Precision Medicine in Respiratory Disease, Departments of Respiratory Medicine and Pediatric Respiratory Medicine, Amsterdam University Medicine Center Information about this upcoming talk, including continuing education, is available below.įor questions about this event or any others in the Discovery Series, please reach out to Veronica Lemme at Precision Medicine in Respiratory Disease: from Biomarkers to Building Consortiums " The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts. The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |